Ken Micklethwaite is the Research Group Leader for Cancer Research at the Westmead Institute and is a haematologist and blood and marrow stem cell transplant physician at Westmead Hospital. He is deputy director of the Sydney Cellular Therapies Laboratory, assisting in running the largest stem cell transplant and clinical cell and gene therapy facilities in NSW (as part of the Sydney Cell and Gene Therapy group at Westmead), with an active research interest in immune therapy of infections and cancer. 


Infection and immunity


Infection and Immunological Conditions

Research Focus

Ken’s primary focus is on developing systems to make cell and gene therapy simpler and more broadly available. He has developed a simplified protocol for generation of gene modified leukaemia and lymphoma-specific immune cells and is in the process of translating this to clinical trials and expanding the technology to target other tumours.

Other Affiliations

Sydney Medical School > Westmead Clinical School > Westmead Clinical School